Search

Your search keyword '"Cordero, Jaclyn"' showing total 8 results
Start Over Author "Cordero, Jaclyn"
8 results on '"Cordero, Jaclyn"'

1. Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM

Author

Moreau, Philippe, Chanan-Khan, Asher, Roberts, Andrew W., Agarwal, Amit B., Facon, Thierry, Kumar, Shaji, Touzeau, Cyrille, Punnoose, Elizabeth A., Cordero, Jaclyn, Munasinghe, Wijith, Jia, Jia, Salem, Ahmed Hamed, Freise, Kevin J., Leverson, Joel D., Enschede, Sari Heitner, Ross, Jeremy A., Maciag, Paulo C., Verdugo, Maria, and Harrison, Simon J.

Published
2017
Full Text
View/download PDF

2. Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.

Author

Costa, Luciano J., primary, Stadtmauer, Edward Allen, additional, Morgan, Gareth John, additional, Monohan, Gregory P., additional, Kovacsovics, Tibor, additional, Burwick, Nicholas, additional, Jakubowiak, Andrzej J., additional, Mobasher, Mehrdad, additional, Freise, Kevin, additional, Ross, Jeremy A., additional, Pesko, John Carl, additional, Munasinghe, Wijith, additional, Cordero, Jaclyn, additional, Morris, Lura, additional, Maciag, Paulo Cesar, additional, Bueno, Orlando, additional, and Kumar, Shaji, additional

Published
2018
Full Text
View/download PDF

4. A Phase 1b Study of Venetoclax Combined with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Author

Moreau, Philippe, primary, Chanan-Khan, Asher, additional, Roberts, Andrew W., additional, Agarwal, Amit B., additional, Facon, Thierry, additional, Kumar, Shaji, additional, Touzeau, Cyrille, additional, Cordero, Jaclyn, additional, Ross, Jeremy, additional, Munasinghe, Wijith, additional, Jia, Jia, additional, Salem, Ahmed H., additional, Leverson, Joel, additional, Maciag, Paulo, additional, Verdugo, Maria, additional, and Harrison, Simon J., additional

Published
2017
Full Text
View/download PDF

5. Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Author

Moreau, Philippe, primary, Chanan-Khan, Asher A., additional, Roberts, Andrew W., additional, Agarwal, Amit B., additional, Facon, Thierry, additional, Kumar, Shaji, additional, Touzeau, Cyrille, additional, Cordero, Jaclyn, additional, Ross, Jeremy, additional, Munasinghe, Wijith, additional, Jia, Jia, additional, Salem, Ahmed H., additional, Leverson, Joel, additional, Maciag, Paulo, additional, Verdugo, Maria, additional, and Harrison, Simon J., additional

Published
2016
Full Text
View/download PDF

6. Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

Author

Moreau, Philippe, primary, Chanan-Khan, Asher Alban Akmal, additional, Roberts, Andrew Warwick, additional, Agarwal, Amit, additional, Facon, Thierry, additional, Kumar, Shaji, additional, Touzeau, Cyrille, additional, Diehl, Susan, additional, Cordero, Jaclyn, additional, Ross, Jeremy A, additional, Munasinghe, Wijith, additional, Zhu, Ming, additional, Salem, Ahmed H., additional, Leverson, Joel, additional, Maciag, Paulo Cesar, additional, Verdugo, Maria E., additional, and Harrison, Simon J, additional

Published
2016
Full Text
View/download PDF

7. A Dose-Escalation Study of Venetoclax (ABT-199/GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

Author

de Vos, Sven, primary, Swinnen, Lode, additional, Kozloff, Mark, additional, Wang, Ding, additional, Reid, Erin, additional, Nastoupil, Loretta, additional, Fowler, Nathan, additional, Cordero, Jaclyn, additional, D'Amico, Diane, additional, Diehl, Susan, additional, Dunbar, Martin, additional, Zhu, Ming, additional, Wong, Shekman, additional, Heitner Enschede, Sari, additional, Chien, David, additional, Humerickhouse, Rod A., additional, and Flowers, Christopher, additional

Published
2015
Full Text
View/download PDF

8. Interim results from a dose-escalation study of the BCL-2 inhibitor venetoclax (ABT-199/GDC-0199) plus bendamustine (B) and rituximab (R) in patients (pts) with relapsed/refractory (R/R) Non-Hodgkin’s Lymphoma (NHL).

Author

De Vos, Sven, primary, Flowers, Christopher, additional, Wang, Ding, additional, Swinnen, Lode J., additional, Fowler, Nathan Hale, additional, Reid, Erin G., additional, Cordero, Jaclyn, additional, Gifford, Maryella, additional, D'Amico, Diane, additional, Dunbar, Martin, additional, Zhu, Ming, additional, Salem, Ahmed H., additional, Enschede, Sari H., additional, Ricker, Justin L., additional, Chien, David, additional, Humerickhouse, Rod, additional, and Kozloff, Mark, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results